Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

International participation

Gene therapy is currently one of the most exciting areas of pharmaceuticals development. Leading researchers and scientists over the world are committed to fulfilling the promise that gene therapy can radically improve the quality of life for millions of people. This dynamic research and development environment is home to CombiGene, Sweden’s only listed gene therapy company. CombiGene’s management group, with CEO Jan Nilsson, Chief Research and Development Officer Karin Agerman and board chairman Arne Ferstad, participate regularly in international congresses and other events to build

NIB finances municipal infrastructure investments in Norrtälje, Sweden

The Nordic Investment Bank (NIB) and the municipality of Norrtälje have signed a 25-year loan facility of SEK 400 million (EUR 38.28 million) to finance investments in water supply, wastewater treatment, new school buildings and a new fire station. The population of the municipality of Norrtälje, located north-east of Stockholm, is expected to exceed 76,000 by 2026. The municipality is therefore investing in the expansion of its infrastructure to accommodate several thousand new households in the coming years. The loan from NIB will finance new educational facilities, including an

Presentation of the interim report for the third quarter 2018

Betsson invites media, analysts and investors to Betsson's office in Stockholm, Sweden, on Wednesday, 24 October, 2018 at 09:00 CET, for the presentation of the interim report with CEO Pontus Lindwall and CFO Kaaren Hilsen. The presentation will be held in English and followed by a questions and answers session. If you are unable to attend the presentation, it is also available via webcast and conference call. The report will be published at 07:30 CET the same day. Please send an e-mail to info@betssonab.com to register to attend the presentation. To participate by phone, please

Lifco publishes its interim report for January-September on 25 October

Lifco  publishes its report for the period January-September on Thursday 25 October at 11.30 a.m. CET. On the same day at 03.00 p.m. CET you are invited to a conference call with Fredrik Karlsson, CEO, Per Waldemarson, deputy CEO and head of business area Dental and Therése Hoffman, CFO. Investors, analysts and media are welcome to take part in the conference call at 03.00 p.m. CET on 25 October. Link to presentation: https://tv.streamfabriken.com/lifco-q3-2018 Call-in numbers: Sweden +46 8 506 395 49UK +44 203 008 98 13US +1 855 753 22 37 The

Mollie and Klarna partner: where simplicity meets flexibility

Klarna’s smooth payment solutions now available as standard for Mollie’s 55,000 SME and Enterprise merchants in the Netherlands, Germany, Austria and FinlandAmsterdam, the Netherlands, October 9, 2018 - Klarna, a leading payment provider, and Mollie, a fast growing payment service provider, are joining forces with the objective to create a simpler and more flexible payment experience for both merchants and customers. This partnership combines two technology-based innovative companies with a shared focus on constantly improving online payments and taking the shopping experience to the next

Read original

Invitation to the presentation of Swedbank's interim report January – September 2018

Swedbank's interim report for January – September 2018 will be published on Tuesday 23 October at 7.00 a.m. (Swedish time). You are cordially invited to participate in the following events:Conference call for investors and equity analysts on 23 October at 8.30 a.m. (Swedish time)Birgitte Bonnesen (President and CEO), Anders Karlsson (CFO), Helo Meigas (CRO) and Gregori Karamouzis (Head of Investor Relations) will present the report. The conference call will be held in English and broadcasted live on www.swedbank.com/ir, where a recording will be available following the call. To

Wärtsilä successfully hands over two new plants to support the UK’s need for fast-starting flexibility

Wärtsilä Corporation, Press release, 9 October 2018 at 11.00 am EESTThe technology group Wärtsilä has successfully handed over two new gas engine plants ordered by Centrica, a British multi-national energy and services company. The project is in line with the company’s strategy for de-centralised power production and will ease the integration of intermittent renewable capacity, notably solar and wind power. Wärtsilä was selected to deliver Engineering, Procurement and Construction (EPC) solutions for both sites, located at Brigg and Peterborough in the UK. The orders were booked in January

Successful tissue machine restart by Valmet at Xiamen Sin Yang Paper Co., Ltd

Valmet Oyj trade press release on October 9, 2018 at 11:00 a.m. EET Valmet's delivery of a tissue machine restart package to Xiamen Sin Yang Paper TM 1 in China concluded with the restart of the machine in September 2018, with a speed of 1,100 m/min. The scope of Valmet's delivery included necessary project management, maintenance, spare parts, and the restart of the tissue machine, which was originally delivered by Valmet but had been idle due to market reasons since 2014. The DCT 200HS tissue machine has now been restarted after a joint effort by Sin Yang Paper, Sen Yang Enterprise (

EVRY ASA: Invitation to presentation of the third quarter results for 2018 on Tuesday 30 October

EVRY ASA will present its third quarter results of 2018 on Tuesday, 30 October 2018. The presentation will take place at EVRYs headquarter at Fornebu at 8:00 CET. · Date: 30 October 2018 · Time: 8:00 CET · Location: Snarøyveien 30, 1360 Fornebu Pre-registration is not required. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast on www.evry.com or followed by telephone at 08:00 CET. Link to webcast and dial-in details will be updated on the company’s website in due time. A replay will be available on www.evry.com soon

2cureX announces CE-IVD marking of its IndiTreat test

2cureX AB (“2cureX”), a leading company in conducting individual treatment design of cancer patients, is pleased to announce the receival of CE-IVD Marking of its product IndiTreat®, which is constructed to tailor individual treatments for colorectal cancer patients. The CE-IVD marking entitles 2cureX the right to sell IndiTreat® tests in Europe.Ole Thastrup, Chief Executive Officer of 2cureX, commented, “The CE-IVD marking of IndiTreat® is a major milestone for 2cureX. Our strong patent portfolio, the CE-IVD marking and our (positive) ongoing multinational clinical trials puts 2cureX in a

Triton has signed an agreement to acquire a majority stake in Norres Group

Frankfurt / Gelsenkirchen (Germany), 9 October 2018 – The Smaller Mid-Cap Fund advised by Triton ("Triton") has signed an agreement to acquire a majority stake in NORRES Group (NORRES), one of Europe’s market leading manufacturer of plastic industrial hoses headquartered in Gelsenkirchen, Germany. Current owner and CEO, Burkhard Mollen, will retain his management position and co-invest alongside Triton. Terms of the acquisition were not disclosed. "We want to support NORRES by investing in accelerated growth and continuous internationalisation of the company. We look forward to working

Financial calendar 2018/2019

Changes to the financial calendar: · The fourth quarter results on 7 February will be extended to include a status update on the strategy and financial targets presented at the capital markets day in 2017. · The ex-dividend date is set to 2 May. 201825 October Q3 2018 20197 February Q4 2018 (extended)7 March Annual report 201830 April Annual general meeting2 May Ex-dividend date3 May Q1 2019as of 10 May Distribution of dividends11 July Q2 201924 October Q3 201920 November Capital markets day

BerGenBio to present interim phase II clinical, preclinical and biomarker data with selective AXL inhibitor bemcentinib at ESMO

Bergen, Norway, 9 October 2018 - BerGenBio ASA (OSE:BGBIO) announces that the company and its collaborators will present interim clinical and biomarker data from its Phase II clinical programme with bemcentinib (BGB324), a first-in-class highly selective oral AXL inhibitor at the ESMO 2018 Congress in Munich (19 - 23 October 2018).Pre-clinical data on the role of AXL inhibition in Myelodysplastic Syndrome (MDS) will also be presented. Details of the presentations are below.  The posters will be made available at www.bergenbio.com in the Investors / Presentations section at the time of

Recipharm releases first serialised products to Europe

Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros in preparing its facilities for the European Falsified Medicines Directive (EU FMD). The release of its first batch of serialised medicine to the European market is a significant milestone in the CDMO's journey towards compliance with the new regulation. Recipharm’s other facilities across Europe will also be ready to release fully

Q3 2018 conference call invitation

MTG will publish its financial results for the third quarter of 2018 at 07:30 CET on Tuesday 23 October and will hold a conference call at 09:00 CET on the same day. The call will be hosted by Jørgen Madsen Lindemann (President & CEO), Anders Jensen (NENT Group President & CEO) and Maria Redin (CFO).To participate, please dial: Sweden: +46 (0)8 5033 6574 UK: +44 (0)330 336 9105 US: +1 323-794-2093 The access pin code for the call is: 4428237 To ensure that the conference call starts on time, please dial in 5-10 minutes before the scheduled start time. The conference call

Wärtsilä’s Interim Report January-September 2018 to be published 23 October 2018 at 8.30 a.m. local time

Wärtsilä Corporation, Press release, 9 October 2018 at 10.00 a.m. EESTWärtsilä Corporation will publish its Interim Report for the period January-September 2018 on Tuesday 23 October 2018 at 8.30 a.m. Finnish time. The report will be available in pdf-format and in a web-based report system at www.wartsilareports.com, as well as on the company website at www.wartsila.com after publishing. An analyst and press conference will be held on the same date, Tuesday 23 October 2018, at 10.00 a.m. Finnish time (8.00 a.m. UK time), at the Wärtsilä headquarters in Helsinki, Finland. The combined web-

Harnessing the wind at sea

Offshore wind power is one of the most promising sources of renewable energy and floating wind farms are in particular an area of growing interest. This is because they have the potential to significantly increase the sea area available for offshore wind farms, especially in countries with limited shallow waters, such as Japan. Floating wind farms can be located further offshore, reducing the eyesore potential for communities[i] , whilst enabling them to reach stronger and more regular winds[ii] .   [i]  Laskow, Sarah (13 September 2011). "

Invitation to media and analyst briefings for Ericsson Q3 2018 report

· Report to be released at approximately 07:30 CEST on October 18, 2018 · Press briefing at Ericsson Studio with live video webcast starts at 09:00 CEST · Conference call for analysts, investors and journalists starts at 14:00 CESTEricsson's (NASDAQ: ERIC) financial report for the third quarter of 2018 will be published at approximately 07:30 CEST on October 18, 2018. The company will issue a press release with the complete financial report attached, including tables, in PDF format. Following publication of the press release, the financial report will be available on Ericsson's

Peab receives contract for ground reinforcement in Spånga

Peab has been commissioned to reinforce the ground in city block Tora, which is the first stage of street work in Bromstensstaden in Spånga. The customer is the City of Stockholm and the contract is worth SEK 116 million.Bromstensstaden is located in northwest Stockholm and there are plans for housing and services in the area. The ground reinforcement project includes soil remediation, provisional rerouting of water, storm water and sewage as well as reinforcing the soil with lime cement pillars in preparation for future construction. Work begins in October 2018 and will continue

Invitation to conference call Interim report January 1 – September 30, 2018

Byggmax interim report for the third quarter 2018 will be published on Thursday October 18, at approximately 08.00 AM. A teleconference will be held on the same day, in English, at 10.30 AM.Byggmax CEO Mattias Ankarberg and CFO Pernilla Walfridsson will present the results for the third quarter 2018 and answer questions.Presentation material will be available from 08.30 AM on October 18 at www.byggmax.se  under Financial Information / Financial reports.To join the conference call the following numbers: from Sweden+ 46 (0)8-566 426 51, from United Kingdom+44 (0)

Itiviti introduces packaged FX trading solution

-       Itiviti FX combines rich out-of-the-box FX trading capabilities with flexible customization options. -       Enables technology consolidation and cross-asset trading strategies. -       Designed to fit into existing trading infrastructure. Stockholm, Sweden, October 9, 2018 – Itiviti, the leading global provider of multi-asset trading technology and financial infrastructure, today introduced Itiviti FX, a comprehensive foreign exchange trading solution built for today’s dynamic FX market landscape and designed for compliance with the latest regulatory requirements including

Neste welcomes Norway’s leadership in reducing emissions from aviation

Neste Corporation, News, 9 October 2018 at 10 am. (EET) The Norwegian government announced on 4th October, that it will introduce a 0.5% biofuel blending mandate for aviation. This is the first time in the world, when biofuel is an essential element in the aviation fuel. "I want to congratulate Norway - their announcement marks a groundbreaking milestone in sustainable aviation. We need forerunners and bold countries, since European regulation seems to have inadequate support to sustainable growth in aviation. The signal Norway's regulation sends to other countries and

Oblique Therapeutics present tumor growth inhibition and Treg-lowering data for OT-1096 in humanized mouse TNBC model at oncology congress ESMO

Gothenburg, 09 Oct 2018 – Oblique Therapeutics, a biotech focused on new medicines for severe diseases with large unmet medical needs, today announced that it will present new promising preclinical data for the drug candidate OT-1096 in triple-negative breast cancer (TNBC) at the largest oncology congress in Europe, the European Society for Medical Oncology (ESMO), held 19-23 October in Munich, Germany.The new data of the first-in-class anti-cancer agent OT-1096 shows promising preliminary results with improved tumor growth inhibition compared to pembrolizumab, one of the blockbuster drugs

ABB expands manufacturing footprint in Indonesia

New gas-insulated switchgear facility to address increased demand for reliable power supplyABB inaugurated a new high-voltage gas-insulated switchgear (GIS) manufacturing facility in Tangerang, on the outskirts of Indonesia’s capital, Jakarta. The unit is the fourth manufacturing facility that ABB has set up in the country during the last three years as part of a $30 million investment plan. The other units manufacture high-voltage air-insulated switchgear, low-voltage, and medium-voltage switchgear. Indonesia, the fourth most populous country in the world, is the largest economy in

There are no items matching the current filter
There are no more items matching the current filter
Back to top